IDXX vs KALA · P/E 40, rev $2.36B vs $54.3M cap
IDEXX Laboratories Inc (IDXX) versus Kala Pharmaceuticals Inc (KALA) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. KALA currently screens at market cap $54.3M.
Not investment advice. Open the IDXX and KALA stock pages for the full models.
Not investment advice.